Tirzepatide, a recently approved medication, is sparking significant excitement in the healthcare community as a possible treatment for both type 2 diabetes and body composition . This dual-action drug works by targeting two different receptors, GLP-1 and GIP, leading to better glycemic management and significant weight reduction in research studie